K. Sel Et Al. , "Palivizumab compliance in congenital heart disease patients: factors related to compliance and altered lower respiratory tract infection viruses after palivizumab prophylaxis," CARDIOLOGY IN THE YOUNG , vol.30, no.6, pp.818-821, 2020
Sel, K. Et Al. 2020. Palivizumab compliance in congenital heart disease patients: factors related to compliance and altered lower respiratory tract infection viruses after palivizumab prophylaxis. CARDIOLOGY IN THE YOUNG , vol.30, no.6 , 818-821.
Sel, K., AYPAR, E., Donmez, Y. N., Aliyev, E., Aykan, H. H., KARAGÖZ, T., ... ALEHAN, D.(2020). Palivizumab compliance in congenital heart disease patients: factors related to compliance and altered lower respiratory tract infection viruses after palivizumab prophylaxis. CARDIOLOGY IN THE YOUNG , vol.30, no.6, 818-821.
Sel, Kutay Et Al. "Palivizumab compliance in congenital heart disease patients: factors related to compliance and altered lower respiratory tract infection viruses after palivizumab prophylaxis," CARDIOLOGY IN THE YOUNG , vol.30, no.6, 818-821, 2020
Sel, Kutay Et Al. "Palivizumab compliance in congenital heart disease patients: factors related to compliance and altered lower respiratory tract infection viruses after palivizumab prophylaxis." CARDIOLOGY IN THE YOUNG , vol.30, no.6, pp.818-821, 2020
Sel, K. Et Al. (2020) . "Palivizumab compliance in congenital heart disease patients: factors related to compliance and altered lower respiratory tract infection viruses after palivizumab prophylaxis." CARDIOLOGY IN THE YOUNG , vol.30, no.6, pp.818-821.
@article{article, author={Kutay Sel Et Al. }, title={Palivizumab compliance in congenital heart disease patients: factors related to compliance and altered lower respiratory tract infection viruses after palivizumab prophylaxis}, journal={CARDIOLOGY IN THE YOUNG}, year=2020, pages={818-821} }